###### Strengths and limitations of this study

-   There have been no previously published studies regarding the relationship between preterm nutritional intake and MRI outcomes at term age.

-   This study provides comprehensive ascertainment of preterm nutritional data in parallel with somatic and brain MRI.

-   Another strength of this study is the use of term born infants as comparator for MRI outcomes.

-   Weaknesses included limited sample size and the prospective observational nature of the study.

Introduction {#s1}
============

Preterm nutritional guidelines are based on consensus expert opinion[@R1] [@R2] rather than compelling evidence and the 'optimal' diet for long-term health remains unknown.[@R3] Though there is now greater clinical emphasis on preterm nutrition, protein deficiency remains a significant risk and our previously published data in 18 preterm infants from a single centre indicate that the preterm diet is low in protein while being high in carbohydrate and fat.[@R4] Our data also suggest that preterm macronutrition may affect later health by demonstrating a positive association between first week lipid intake in preterm infants and elevated intrahepatocellular lipid, which in adults is associated with the cardiometabolic syndrome.[@R5]

The preterm phenotype at term is characterised by aberrant adipose tissue (AT) partitioning,[@R6] reduced proximal cerebral arterial vessel tortuosity (CAVT),[@R7] reduced deep grey matter volumes[@R8] and reduced cerebral cortical folding.[@R9] The somatic phenotype observed is a matter of concern as adiposity is associated with inflammation and reduced brain volume in the adult population.[@R10]

Here, we present prospective observational data designed to (1) assess the influence of nutrition on the preterm phenotype at term age, (2) describe phenotypic differences between preterm infants at term and term healthy infants and (3) examine relationships between somatic and brain MRI measurements. The a priori hypotheses of our study were that (1) preterm macronutrient intake would be positively associated with central nervous system phenotype (brain volume and cerebral vessel tortuosity) and (2) preterm macronutrient intake would be negatively associated with internal abdominal (visceral) adiposity. The relationship between somatic and brain MRI outcomes represents a post hoc exploratory analysis.

Patients and methods {#s2}
====================

Following research ethics approval (REC 07/Q0403/46) and informed parental consent, preterm infants admitted to the Chelsea and Westminster Hospital Neonatal Unit, London, UK (\<32 weeks of gestation) and term infants (37--42 weeks gestation) on the postnatal ward were recruited (January 2007--July 2008). Infants with congenital anomalies were excluded.

Preterm nutrition and growth {#s2a}
----------------------------

Preterm nutritional practice during the study period has been previously described.[@R4] In brief, enteral feeds were started on day 1 with either maternal expressed breast milk or donor expressed breast milk prior to consideration of the use of formula. Human milk fed infants received Nutriprem breast milk fortifier (Cow & Gate) once 150 mL/kg/day of feed volume was reached. Parenteral nutrition was started on the day of birth.

Weight and head circumference data for the preterm group are expressed as SD scores (SDS) at birth and at the time of MRI. Birth length was not routinely measured during the study period. Macronutrient and human milk intake was recorded between birth and 34^+6^ weeks postmenstrual age (PMA) using a nutritional data capture system designed in-house (Nutcracker, Imperial College, London, UK). Macronutrient data were expressed as the difference between recommended daily intake (RDI) from Tsang *et al*[@R1] and actual daily intake in grams or kilocalories/kilogram for the period of either early (first week of life) or total nutrition (birth and 34^+6^ PMA).[@R4] Human milk intake is expressed as mL/kg/day and as percentage of enteral feeds given as human milk.

MRI {#s2b}
---

MRI was performed at the Robert Steiner Unit, Hammersmith Hospital shortly after discharge from the neonatal unit as previously described[@R4] using a Philips Achieva system (Best, the Netherlands).

### Total and regional AT {#s2b1}

Imaging parameters are shown in [table 1](#BMJOPEN2014005390TB1){ref-type="table"}. Regional AT depots were classified as total superficial subcutaneous, total deep subcutaneous and total internal and subdivided into abdominal or non-abdominal ([figures 1](#BMJOPEN2014005390F1){ref-type="fig"} and [2](#BMJOPEN2014005390F2){ref-type="fig"}). AT volumes were calculated as previously described.[@R6] Non-AT mass was calculated by conversion of AT volume to AT mass (density of AT of 0.9 g/cm^3^) and subtraction of the result from weight at the time of MRI.

###### 

MRI parameters for adipose tissue, brain volume and proximal cerebral arterial vessel tortuosity

                                                      Planes           Weighting           FOV   Slices   Slice thickness (mm)   Slice gap (mm)   TE (ms)   TR (ms)        Acquisition time (s)
  --------------------------------------------------- ---------------- ------------------- ----- -------- ---------------------- ---------------- --------- -------------- ----------------------
  Adipose tissue[@R6]                                 Axial            T1 fast spin echo   300   25       5                      5                20        500            360
  Brain volume[@R11]                                  Axial/sagittal   T2                  220   60       3                      −1.5             160       16646/38 662   425
  Proximal cerebral arterial vessel tortuosity[@R7]   Axial/sagittal   Angiogram           175   100      0.6                    0                8.06      19             329

![Classification of adipose tissue depots into internal, superficial subcutaneous and deep subcutaneous depots and further subclassification according to abdominal or non-abdominal position.](bmjopen2014005390f01){#BMJOPEN2014005390F1}

![T1-weighted axial MRI (abdominal level) demonstrating the deep and superficial subcutaneous adipose tissue depots. A clear fascial plane is noted between the superficial and deep subcutaneous layers (arrows).](bmjopen2014005390f02){#BMJOPEN2014005390F2}

### Brain volume {#s2b2}

T2-weighted images were acquired using a dynamic sequence of six separate loops of single shot images which were then registered and reconstructed to produce volumetric datasets to eliminate the effects of motion artefact.[@R11] Imaging parameters are shown in [table 1](#BMJOPEN2014005390TB1){ref-type="table"}. Images were corrected for radiofrequency inhomogeneity (<http://mipav.cit.nih.gov>). BET Brain extraction tool FSL V.3 (<http://www.fmrib.ox.ac.uk/fsl/>)[@R12] was then used to delete non-brain tissue and create binary brain masks representing intracranial volume.[@R13] A mask of ventricular and cerebrospinal fluid (CSF) spaces was created using the thresholding feature of Image J, a java-based image processing program.[@R14] Brain volume was calculated by subtraction of the volume of the ventricular and CSF masks from the volume of the intracranial mask using ImageJ ([figure 3](#BMJOPEN2014005390F3){ref-type="fig"}). Brain MRIs were reported by MR for clinical purposes and given a score (0--13) adapted from Dyet *et al*[@R15] so that, if necessary, pathological findings could be accounted for.

![(A) T2-weighted MRI undergoes RF inhomogeneity correction and subsequent creation of a binary brain mask of intracranial volume (BET brain extraction tool FSL V.3). (B) Creation of a mask of the ventricular and cerebrospinal fluid spaces using the thresholding feature of ImageJ V.1.38. (C) Calculation of actual brain volume by subtraction of ventricular and cerebrospinal volume from intracranial volume.](bmjopen2014005390f03){#BMJOPEN2014005390F3}

### Proximal CAVT measurement and analysis {#s2b3}

An optimised neonatal three-dimensional time of flight MR angiography sequence was used to assess the anterior, middle and posterior cerebral arteries.[@R7] Imaging parameters are shown in [table 1](#BMJOPEN2014005390TB1){ref-type="table"}. Vessel tortuosity was assessed using a previously validated measurement, distance factor[@R16] ([figure 4](#BMJOPEN2014005390F4){ref-type="fig"}), and a CAVT score was determined as a global measure of tortuosity for each participant by calculating the mean of the anterior cerebral artery, middle cerebral artery and posterior cerebral artery distance factor.

![(A) Axial MR angiogram demonstrating the tracing of a contour along the left middle cerebral artery for 30 mm (black line) along with a straight line measurement between the start point and the end point of the traced contour (red line). (B) Sagittal MR angiogram demonstrating the tracing of a contour along the anterior cerebral artery for 30 mm (black line) along with a straight line measurement between the start point and the end point of the traced contour (red line).](bmjopen2014005390f04){#BMJOPEN2014005390F4}

Illness severity {#s2c}
----------------

CRIB II Score was calculated in preterm infants.[@R17]

Sample size calculation and analyses {#s2d}
------------------------------------

Based on previous work,[@R6] we estimated that recruitment of 60 preterm and 60 term infants allowed detection of a 0.5 SD difference between the groups for AT volume (power 80%, significance 5%). As this was an exploratory hypothesis-generating prospective observational study and given the uncertainty as to what differences were of clinical importance, additional sample size calculations were not considered. Data were adjusted for relevant confounding variables where appropriate and are presented for each of the MR outcomes with a comparison of outcomes between the groups. Data were analysed by comparison of means and tested for normality. Parametric or non-parametric methods were then applied accordingly. Within the preterm group, Pearson correlation was used to investigate the relationship between nutrition and MR outcomes at term age and these were limited to the patients in whom both nutritional data and the MRI outcome were successfully acquired. For a multivariate analysis, a minimum of 10n participants is considered appropriate, where n is the number of covariates. Data are presented as mean (SD) or mean (95% CI).

Results {#s3}
=======

Sixty-one infants were recruited during the study (preterm 22, term 39). MR images without motion artefact were acquired as follows: AT volume (preterm 22, term 39), brain volume (preterm 19, term 19) and CAVT measurement (preterm 20, term 13). In preterm infants, mean (SD) CRIB II score was 7.6 (4.2). Twenty-five per cent had chronic lung disease of prematurity (defined as an oxygen requirement at 36 weeks PMA), 20% had a patent ductus arteriosus requiring pharmacological therapy, 5% had retinopathy of prematurity requiring laser therapy and 5% had a large intraventricular haemorrhage (grade III/IV Papile classification). 0% had necrotising enterocolitis requiring surgery. [Table 2](#BMJOPEN2014005390TB2){ref-type="table"} summarises the baseline and imaging characteristics and the MR outcomes of the preterm and term groups.

###### 

Birth characteristics, imaging characteristics and MRI outcomes in preterm-at-term and term infants

                                                           Preterm-at-term           n    Term                      n    95% CI for difference
  -------------------------------------------------------- ------------------------- ---- ------------------------- ---- ----------------------------
  Birth characteristics                                                                                                  
   Gestation at birth (weeks)                              28.9 (2.8)                22   40.2 (1.20)               39   N/A
   Birth weight (kg)                                       1.26 (0.41)               22   3.40 (0.45)               39   N/A
   Gestation at MRI (weeks)                                40.2 (3.10)               22   41.4 (1.40)               39   N/A
  Anthropometry at the time of MRI                                                                                       
   Weight at MRI (kg)                                      3.01 (2.83--3.19)         22   3.30 (3.17--3.44)         39   0.30 (0.66 to 0.53)\*
   Length at MRI (cm)                                      47.9 (46.9--48.9)         22   51.3 (50.5--52.1)         39   3.4 (2.1 to 4.7)\*\*
   Head circumference at MRI (cm)                          34.2 (33.6--34.7)         22   35.2 (34.8--35.6)         39   1.1 (0.4 to 1.7)\*\*
  Somatic MRI outcomes                                                                                                   
   Total AT (L)                                            0.782 (0.735--0.829)      22   0.657 (0.623--692)        39   0.125 (0.064 to 0.186)\*\*
   Total deep subcutaneous AT (L)                          0.033 (0.029--0.036)      22   0.024 (0.021--0.027)      39   0.009 (0.004 to 0.013)\*\*
   Total superficial subcutaneous AT (L)                   0.673 (0.631--0.715)      22   0.568 (0.538--0.599)      39   0.105 (0.051 to 0.159)\*\*
   Total internal AT (L)                                   0.076 (0.069--0.083)      22   0.065 (0.060--0.070)      39   0.011 (0.002 to 0.020)\*
   Deep subcutaneous adipose abdominal AT (L)              0.017 (0.014--0.019)      22   0.012 (0.011--0.014)      39   0.004 (0.001 to 0.005)\*\*
   Deep subcutaneous adipose non-abdominal AT (L)          0.016 (0.014--0.018)      22   0.012 (0.010--0.013)      39   0.004 (0.002 to 0.007)\*\*
   Superficial subcutaneous adipose abdominal AT (L)       0.133 (0.122--0.145)      22   0.091 (0.083--0.100)      39   0.042 (0.027 to 0.057)\*\*
   Superficial subcutaneous adipose non-abdominal AT (L)   0.540 (0.506--0.574)      22   0.477 (0.452--0.502)      39   0.063 (0.019 to 0.107)\*\*
   Internal abdominal AT (L)                               0.022 (0.019--0.025)      22   0.018 (0.016--0.021)      39   0.004 (0 to 0.007)
   Internal non abdominal AT (L)                           0.054 (0.049--0.060)      22   0.047 (0.043--0.051)      39   0.008 (0.001 to 0.005)\*
   Non-AT mass (kg)                                        2.49 (2.45--2.54)         22   2.61 (2.57--2.64)         39   0.12 (0.06 to 0.170)\*\*
  Brain MRI outcomes                                                                                                     
   Brain volume (mL)                                       481.46 (462.29--498.63)   19   474.02 (456.85--491.20)   19   7.44 (18.53 to 33.40)
   Cerebrospinal fluid volume (mL)                         63.78 (55.06--72.50)      19   31.44 (22.72--40.16)      19   32.34 (19.15 to 45.53)\*\*
   Anterior cerebral artery DF                             1.38 (1.30--1.46)         20   1.25 (1.19--1.32)         13   0.13 (0.03 to 0.23)\*
   Middle cerebral artery DF                               1.38 (1.32--1.44)         20   1.26 (1.21--1.31)         13   0.12 (0.04 to 0.19)\*\*
   Posterior cerebral artery DF                            1.46 (1.41--1.50)         20   1.27 (1.24--1.30)         13   0.19 (0.14 to 0.24)\*\*
   Proximal CAVT score                                     1.41 (1.36--1.45)         20   1.26 (1.23--1.29)         13   0.14 (0.09 to 0.20)\*\*

Results are mean (SD) or mean (95% CI).

\*p\<0.05, \*\*p\<0.01.

AT, adipose tissue; CAVT, cerebral arterial vessel tortuosity; DF, distance factor; L, litres; n, sample size.

Preterm nutrition and growth {#s3a}
----------------------------

Growth and nutrition data for the preterm cohort have been previously published.[@R4] In brief, the mean (SD) for birth weight and birth head circumference SDS were: −0.13 (0.78) and −0.64 (1.12). At the time of MRI, the respective values were −1.39 (0.93) and −0.86 (1.33). Weight gain was mean (SD) 9.48 (1.73) g/kg/day between birth and 34^+6^ weeks. Preterm macronutrient intakes for both the first week after birth and for the period from birth until 34^+6^ weeks PMA revealed a mean protein deficit (first week: −1.6 g/kg/day; birth until 34^+6^ weeks −0.4 g/kg/day) in the context of excessive carbohydrate and fat intake. Mean (SD) human milk intakes for these periods were 36.6 (29.7) and 108.9 (46.6) mL/kg/day, respectively.

Preterm nutrition and MRI outcomes {#s3b}
----------------------------------

### Human milk and MRI outcomes {#s3b1}

After adjustment for weight at MRI, there was no correlation between early or total human milk intake and either regional AT volumes or brain volume at term age. There was no correlation between early human milk intake and overall CAVT score (r=0.31, p=0.18); however, there was a weak positive relationship between total human milk intake and overall CAVT score (r=0.44, p=0.05) ([figure 5](#BMJOPEN2014005390F5){ref-type="fig"}). This relationship was also apparent when total human milk intake was expressed as a percentage of total milk intake (r=0.45, p=0.04).

![Relationship between proximal cerebral arterial vessel tortuosity (CAVT) score at term and total human milk intake (birth to 34^+6^ weeks PMA) in preterm infants.](bmjopen2014005390f05){#BMJOPEN2014005390F5}

### Macronutrient intake and MRI outcomes {#s3b2}

There were no correlations between macronutrient intake (protein, carbohydrate, fat) and total adiposity (n=22). After adjustment for PMA, neither early nor total preterm macronutrient intake was correlated with brain volume at term age (n=19). There were no relationships noted between early or total macronutrient intake and proximal CAVT score (n=20), a summary measure of tortuosity.

Preterm at term versus term group comparison {#s3c}
--------------------------------------------

### Anthropometry {#s3c1}

Anthropometric data were adjusted for PMA at the time of MRI. Preterm infants were smaller, shorter and had smaller head circumferences than term infants ([table 2](#BMJOPEN2014005390TB2){ref-type="table"}).

### Adiposity {#s3c2}

Adipose tissue data were adjusted for PMA at the time of MRI. Preterm infants had more AT than term infants with expansion of the superficial subcutaneous, deep subcutaneous and internal AT depots. There was a parallel reduction in non-AT mass ([table 2](#BMJOPEN2014005390TB2){ref-type="table"}).

### Brain volume {#s3c3}

Brain MRI scores in the cohort of preterm infants were mean (SD) 3.6 (2.1). There was no correlation between brain MRI score and brain volume (r=0.31, p=0.20). At term age, preterm brain volumes were smaller than those for term infants (PT 461.74 (436.16--487.32) mL vs 493.74 (476.43--511.05) mL, p=0.05). However, after adjustment for weight at the time of MRI, a significant confounding factor, there was no difference between the groups. Preterm-at-term infants had significantly increased CSF volume ([table 2](#BMJOPEN2014005390TB2){ref-type="table"}).

### Distance factor and proximal CAVT score {#s3c4}

In comparison to term born infants, preterm-at-term infants had a significant reduction in CAVT ([table 2](#BMJOPEN2014005390TB2){ref-type="table"}).

Relationships between somatic and central nervous system MRI phenotype {#s3d}
----------------------------------------------------------------------

After adjustment for weight at MRI, there was a significant negative correlation noted in preterm-at-term infants but not in term infants, between deep subcutaneous AT volume and brain volume (r=−0.58, p=0.01) ([table 3](#BMJOPEN2014005390TB3){ref-type="table"}). There were no statistically significant correlations between regional AT and CAVT score.

###### 

Pearson correlations between regional AT depots and brain volume in preterm-at-term and term infants adjusted for weight at imaging

  Regional AT depot   Preterm-at-term (n=19)   Term (n=19)
  ------------------- ------------------------ ---------------
  Total AT            −0.23, p=0.38            −0.23, p=0.35
  Total DSC AT        −0.58, p=0.01\*          −0.05, p=0.85
  Total SSC AT        −0.22, p=0.39            −0.24, p=0.34
  Total I AT          −0.09, p=0.73            −0.13, p=0.96

AT, total adipose tissue; IA AT, internal abdominal adipose tissue; Total DSC AT, total deep subcutaneous adipose tissue, Total I AT, total internal adipose tissue; Total SSC AT, total superficial subcutaneous adipose tissue.

Discussion {#s4}
==========

We identify novel findings of interest including a positive association between human milk intake and proximal CAVT, a marker of cerebrovascular development and a negative correlation between regional adipose tissue volume and brain volume in preterm infants. The study also comprehensively characterises the somatic and brain phenotypes of a cohort of preterm infants at term in comparison to term born healthy infants and demonstrates (1) reduced anthropometric measures, (2) increased total and regional adiposity, (3) reduced non-adipose tissue mass, (4) comparable brain volumes, (5) increased CSF volume and (6) reduced proximal cerebral arterial vessel tortuosity. We have shown no relationship with either body composition or brain volume at term age within the range of macronutritional intakes received by the preterm infants in this study.

Key study strengths include the comprehensive ascertainment of preterm nutritional data and the assessment of a number of MR outcomes. Limitations include the prospective observational design of the study that preclude any inferences regarding causality, and the 'suboptimal' preterm nutritional intake, a potential determinant of the observed phenotype. Successful acquisition of a number of different MR outcomes without use of sedation was challenging and the motion artefact meant that not all recruited infants had data of sufficient quality for analysis. We were unable to recruit the desired number of infants and recognise that the study may be underpowered. The preterm infants studied were relatively healthy, as evidenced by low illness severity (CRIB II scores), low incidences of serious neonatal morbidity and low brain MR scores, factors that may have attenuated any associations with nutritional intake.

The finding of increased adiposity in preterm infants confirms our previous work.[@R6] We have previously shown expansion of the internal abdominal AT compartment in preterm-at-term infants in comparison to term born infants in a cohort of preterm infants recruited in 2002--2003,[@R6] a time at which neonatal nutrition was possibly not as carefully considered as it is today. This contrasts with our present data which demonstrate a global expansion of all AT depots. Whether the differences observed in AT partitioning between these studies relate to changes in nutritional practices and the provision of a more calorie dense diet is a plausible but as yet unproven hypothesis. Other potential mechanisms, which we have not explored, that might explain the increased adiposity seen in preterm infants include weight cycling and inflammation. It is known that cycling between high-calorie diets and low-calorie diets (weight cycling)[@R18] results in the preferential deposition of AT over non-AT mass[@R19] and this phenomenon often occurs in preterm infants when enteral feeds are discontinued because of concerns regarding feed intolerance and then restarted. Inflammation is also a known determinant of adiposity[@R20] and it is possible that the proinflammatory milieu often present in the perinatal period (maternal chorioamnionitis, use of intravenous lipid formulations high in omega-6 fatty acids and postnatal infection/ inflammation) may be relevant to the observed phenotype.

The nutritional intake received by this cohort of preterm infants was imbalanced (low in protein and high in fat and carbohydrate) and suboptimal in relation to expert consensus recommendations.[@R1] [@R2]) In animal models, protein deficiency is associated with a number of adverse health outcomes including a reduction in lifespan,[@R21] cardiovascular dysfunction,[@R22] reduced dendritic spine density[@R23] reduced brain weight[@R24] and reduced cortical blood vessel density[@R25] Human adult data indicate that dietary protein is an important factor in body weight regulation.[@R26] Recent data in human ex-preterm infants suggest an association between early growth patterns and fractional anisotropy, a measure of brain microstructure.[@R27] Our group has previously shown that preterm-at-term AT deposition can be attenuated by use of fortified human milk.[@R28] Whether this translates into a longer term benefit is unknown.

The negative correlation we show between adiposity in preterm-at-term infants and brain volume is consistent with the findings in adults and children[@R10] [@R29] [@R30]. This, notwithstanding preterm-at-term brain volume, was comparable to that of term born healthy infants, which is also in keeping with previously published work.[@R31] This, together with the finding of maintained head circumference SDS between birth and time of imaging, may be indicative of 'brain sparing' in nutritionally compromised infants.

We have confirmed the finding of reduced proximal CAVT in preterm infants.[@R7] Though the natural history and long-term neurodevelopmental sequelae of reduced CAVT are unknown, epidemiological data indicate that advancing gestation confers a significant reduction in risk of fatal adult cerebrovascular disease (occlusive stroke).[@R32] Our observation that human milk may be protective despite low macronutrient density suggests that non-nutritive factors, such as vascular endothelial growth factor, may play an important role in cerebrovascular development.

In conclusion, we have extended the characterisation of the preterm-at-term phenotype. Our data do not support an association between macronutrient intake and body composition or brain volume. Other plausible determinants that remain to be explored are the roles of micronutrient deficiency, weight cycling, disease severity and chronic inflammation.
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